The Discounted Cash Flow (DCF) valuation of Collegium Pharmaceutical Inc (COLL) is 60.87 USD. With the latest stock price at 32.59 USD, the upside of Collegium Pharmaceutical Inc based on DCF is 86.8%.
Based on the latest price of 32.59 USD and our DCF valuation, Collegium Pharmaceutical Inc (COLL) is a buy. buying COLL stocks now will result in a potential gain of 86.8%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 9.0% | 7.6% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 34.57 - 140.85 | 60.87 |
| Upside | 6.1% - 332.2% | 86.8% |